What's happening
This bill requires insurance policies in New York to cover testing for familial dysautonomia, Canavan's disease, and Tay-Sachs.
Why it matters
Expands access to critical genetic testing. for conditions (familial dysautonomia, Canavan’s disease, Tay-Sachs) that disproportionately affect certain populations and can have major implications for family planning, early diagnosis, and intervention.
Reduces financial barriers. by requiring insurance coverage for these tests, which can otherwise be expensive and not routinely included in standard insurance policies, making them more accessible to at-risk individuals.
Protects patient confidentiality. by specifying that only a laboratory acknowledgment is needed as proof of testing, minimizing unnecessary disclosure of sensitive genetic information to insurers or third parties.
Integrates coverage into existing insurance frameworks. , applying to new and renewing policies, but allows insurers to apply standard deductibles and co-insurance, ensuring parity with other medical benefits and potentially limiting premium increases.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Cover Genetic Disease Testing
Plain English, a few words. Used as the page title.
Sponsors
History
- Referred to insurance
- Referred to insurance
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Cover Rare Genetic Disease Tests
In Senate Committee · Insurance · Sponsor Cordell Cleare
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
1792
2023-2024 Regular Sessions
IN ASSEMBLY
January 23, 2023
Introduced by M. of A. DINOWITZ, PAULIN, BURDICK, BRAUNSTEIN, SILLITTI, HEVESI, COOK, SIMON, McDONOUGH -- read once and referred to the Committee on Insurance
AN ACT to amend the insurance law, in relation to reimbursement for testing for familial dysautonomia, Canavan's disease and Tay-Sachs
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subsection (i) of section 3216 of the insurance law is amended by adding a new paragraph 37 to read as follows:
(37) (A) Every policy which provides coverage for hospital, surgical or medical care or provides reimbursement for laboratory tests or reimbursement for diagnostic X-ray services shall provide coverage for testing for familial dysautonomia, Canavan's disease and Tay-Sachs.
(B) Such coverage shall be included at the inception of all new policies and, with respect to all other policies, at any anniversary date of the policy subject to evidence of insurability.
(C) For purposes of this paragraph, in order to maintain the confidentiality of persons tested, receipt of an acknowledgment from the laboratory performing the test for familial dysautonomia, Canavan's disease and Tay-Sachs shall be deemed sufficient evidence of the performance of such testing.
(D) Such coverage may be subject to annual deductibles and co-insurance as may be deemed appropriate by the superintendent and as are consistent with those established for other benefits within a given policy.
§ 2. Subsection (l) of section 3221 of the insurance law is amended by adding a new paragraph 21 to read as follows:
(21) (A) A group policy which provides coverage for hospital, surgical or medical care or provides reimbursement for laboratory tests or reimbursement for diagnostic X-ray services shall provide coverage for testing for familial dysautonomia, Canavan's disease and Tay-Sachs.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD00847-01-3
(B) Such coverage shall be included at the inception of all new policies and, with respect to all other policies, at any anniversary date of the policy subject to evidence of insurability.
(C) For purposes of this paragraph, in order to maintain the confidentiality of persons tested, receipt of an acknowledgment from the laboratory performing the test for familial dysautonomia, Canavan's disease and Tay-Sachs shall be deemed sufficient evidence of the performance of such testing.
(D) Such coverage may be subject to annual deductibles and co-insurance as may be deemed appropriate by the superintendent and as are consistent with those established for other benefits within a given policy.
§ 3. Section 4303 of the insurance law is amended by adding a new subsection (tt) to read as follows:
(tt) (1) A medical expense indemnity corporation, a hospital service corporation or a health service corporation which provides coverage for hospital, surgical or medical care or provides reimbursement for laboratory tests or reimbursement for diagnostic X-ray services shall provide coverage for testing for familial dysautonomia, Canavan's disease and Tay-Sachs.
(2) Such coverage shall be included at the inception of all new policies and, with respect to all other policies, at any anniversary date of the policy subject to evidence of insurability.
(3) For purposes of this subsection, in order to maintain the confidentiality of persons tested, receipt of an acknowledgment from the laboratory performing the test for familial dysautonomia, Canavan's disease and Tay-Sachs shall be deemed sufficient evidence of the performance of such testing.
(4) Such coverage may be subject to annual deductibles and co-insurance as may be deemed appropriate by the superintendent and as are consistent with those established for other benefits within a given policy.
§ 4. This act shall take effect immediately.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.